Meeder Asset Management’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History

Meeder Asset Management’s Portfolio SCMP Stock Details SCMP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-76	Closed	-$1K	–	1858
2017 Q4	$1K	Sell	76 -251	-77%	-$3.09K	﹤0.01%	1635
2017 Q3	$4K	Hold	327	–	–	﹤0.01%	1356
2017 Q2	$3K	Hold	327	–	–	﹤0.01%	1368
2017 Q1	$4K	Hold	327	–	–	﹤0.01%	1227
2016 Q4	$4K	Buy	+327	New	+$4.56K	﹤0.01%	895
2016 Q3	–	Sell	-8,077	Closed	-$89K	–	1055
2016 Q2	$89K	Sell	8,077 -2,323	-22%	-$26K	0.01%	677
2016 Q1	$114K	Sell	10,400 -5,817	-36%	-$73.5K	0.01%	679
2015 Q4	$281K	Sell	16,217 -247,345	-94%	-$4.43M	0.03%	470
2015 Q3	$5.24M	Buy	+263,562	New	+$6.04M	0.51%	43

Other funds holding SCMP

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

AIM

Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Meeder Asset Management's SCMP Position: Q1 2018 in Review

Meeder Asset Management sold out of Sucampo Pharmaceuticals, Inc. (SCMP) in Q1 2018, closing a stake of 76 shares — an estimated $1K sold.

Meeder Asset Management first reported a position in SCMP in Q3 2015 and held it in 9 quarters. The position peaked at $5.24M in Q3 2015. 3 funds tracked by Wall St. Rank hold SCMP as of Q1 2018.

Meeder Asset Management reported no remaining Sucampo Pharmaceuticals, Inc. position as of Q1 2018 after selling out during the quarter.
Meeder Asset Management sold 76 Sucampo Pharmaceuticals, Inc. shares in Q1 2018, an estimated $1K.
Meeder Asset Management first reported a position in Sucampo Pharmaceuticals, Inc. in Q3 2015 and held it in 9 quarters.
Meeder Asset Management's Sucampo Pharmaceuticals, Inc. position peaked at $5.24M in Q3 2015.
3 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q1 2018.

Based on Meeder Asset Management's 13F filing for Q1 2018, filed 3 May 2018.